Genetic Technologies Ltd GTG-AU:ASX

*Data is delayed | AUD
Last | 09/17/21 AET
0.008UNCH (UNCH)
Volume
100,000
52 week range
0.01 - 0.01
Loading...
  • Open0.008
  • Day High0.008
  • Day Low0.008
  • Prev Close0.008
  • 52 Week High0.01
  • 52 Week High Date02/18/21
  • 52 Week Low0.01
  • 52 Week Low Date11/25/20

Key Stats

  • Market Cap53.31M
  • Shares Out9,016.73M
  • 10 Day Average Volume1.24M
  • Dividend-
  • Dividend Yield-
  • Beta1.31
  • YTD % Change6.67

KEY STATS

  • Open0.008
  • Day High0.008
  • Day Low0.008
  • Prev Close0.008
  • 52 Week High0.01
  • 52 Week High Date02/18/21
  • 52 Week Low0.01
  • 52 Week Low Date11/25/20
  • Market Cap53.31M
  • Shares Out9,016.73M
  • 10 Day Average Volume1.24M
  • Dividend-
  • Dividend Yield-
  • Beta1.31
  • YTD % Change6.67

RATIOS/PROFITABILITY

  • EPS (TTM)-0.00
  • P/E (TTM)-10.00
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Genetic Technologies Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company focuses on the development and commercialization of genetic risk assessment technology for contracting cancer and other chronic diseases. The Company operates through two geographic segments: Australia and United states of America (USA). Australia segment is the home country of the parent entity and the location of the Company's genetic testing and licensing operations....
Peter Rubenstein
Chairman
Simon Morriss
Chief Executive Officer
Stan Sack
Chief Operating Officer
Michael Tonroe
Chief Financial Officer
Address
60-66 Hanover St, Fitzroy
Melbourne, VIC
3065
Australia